BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 11719510)

  • 21. Proteases involved in MHC class II antigen presentation.
    Villadangos JA; Bryant RA; Deussing J; Driessen C; Lennon-Duménil AM; Riese RJ; Roth W; Saftig P; Shi GP; Chapman HA; Peters C; Ploegh HL
    Immunol Rev; 1999 Dec; 172():109-20. PubMed ID: 10631941
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Differential regulation of cathepsin S and cathepsin L in interferon gamma-treated macrophages.
    Beers C; Honey K; Fink S; Forbush K; Rudensky A
    J Exp Med; 2003 Jan; 197(2):169-79. PubMed ID: 12538657
    [TBL] [Abstract][Full Text] [Related]  

  • 23. MHC class I presentation of an exogenous polypeptide antigen encoded by the murine AIDS defective virus.
    Yee ST; Okada Y; Ogasawara K; Omura S; Takatsuki A; Kakiuchi T; Muno D; Kominami E; Mizuochi T
    Microbiol Immunol; 1997; 41(7):563-70. PubMed ID: 9272702
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Gamma-interferon causes a selective induction of the lysosomal proteases, cathepsins B and L, in macrophages.
    Lah TT; Hawley M; Rock KL; Goldberg AL
    FEBS Lett; 1995 Apr; 363(1-2):85-9. PubMed ID: 7729559
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Tumor necrosis factor alpha and interleukin-1 alpha inhibit through different pathways interferon-gamma-induced antigen presentation, processing and MHC class II surface expression on astrocytes, but not on microglia.
    Gresser O; Hein A; Riese S; Régnier-Vigouroux A
    Cell Tissue Res; 2000 Jun; 300(3):373-82. PubMed ID: 10928267
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cathepsins B and D are dispensable for major histocompatibility complex class II-mediated antigen presentation.
    Deussing J; Roth W; Saftig P; Peters C; Ploegh HL; Villadangos JA
    Proc Natl Acad Sci U S A; 1998 Apr; 95(8):4516-21. PubMed ID: 9539769
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pepstatin A-sensitive aspartic proteases in lysosome are involved in degradation of the invariant chain and antigen-processing in antigen presenting cells of mice infected with Leishmania major.
    Zhang T; Maekawa Y; Yasutomo K; Ishikawa H; Fawzy Nashed B; Dainichi T; Hisaeda H; Sakai T; Kasai M; Mizuochi T; Asao T; Katunuma N; Himeno K
    Biochem Biophys Res Commun; 2000 Sep; 276(2):693-701. PubMed ID: 11027533
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Intestinal epithelial cells use two distinct pathways for HLA class II antigen processing.
    Hershberg RM; Framson PE; Cho DH; Lee LY; Kovats S; Beitz J; Blum JS; Nepom GT
    J Clin Invest; 1997 Jul; 100(1):204-15. PubMed ID: 9202073
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cathepsin L maturation and activity is impaired in macrophages harboring M. avium and M. tuberculosis.
    Nepal RM; Mampe S; Shaffer B; Erickson AH; Bryant P
    Int Immunol; 2006 Jun; 18(6):931-9. PubMed ID: 16636015
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Expression and upregulation of cathepsin S and other early molecules required for antigen presentation in activated hepatic stellate cells upon IFN-gamma treatment.
    Maubach G; Lim MC; Kumar S; Zhuo L
    Biochim Biophys Acta; 2007 Feb; 1773(2):219-31. PubMed ID: 17178165
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Human cathepsin S, but not cathepsin L, degrades efficiently MHC class II-associated invariant chain in nonprofessional APCs.
    Bania J; Gatti E; Lelouard H; David A; Cappello F; Weber E; Camosseto V; Pierre P
    Proc Natl Acad Sci U S A; 2003 May; 100(11):6664-9. PubMed ID: 12748383
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antigen processing for presentation by class II major histocompatibility complex requires cleavage by cathepsin E.
    Bennett K; Levine T; Ellis JS; Peanasky RJ; Samloff IM; Kay J; Chain BM
    Eur J Immunol; 1992 Jun; 22(6):1519-24. PubMed ID: 1601038
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cathepsin S inhibitor prevents autoantigen presentation and autoimmunity.
    Saegusa K; Ishimaru N; Yanagi K; Arakaki R; Ogawa K; Saito I; Katunuma N; Hayashi Y
    J Clin Invest; 2002 Aug; 110(3):361-9. PubMed ID: 12163455
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A role for cathepsin E in the processing of mast-cell carboxypeptidase A.
    Henningsson F; Yamamoto K; Saftig P; Reinheckel T; Peters C; Knight SD; Pejler G
    J Cell Sci; 2005 May; 118(Pt 9):2035-42. PubMed ID: 15860733
    [TBL] [Abstract][Full Text] [Related]  

  • 35. MHC class II antigen presentation pathway in murine tumours: tumour evasion from immunosurveillance?
    Walter W; Lingnau K; Schmitt E; Loos M; Maeurer MJ
    Br J Cancer; 2000 Nov; 83(9):1192-201. PubMed ID: 11027433
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Differences in antigen processing with haplotype-mismatched MHC class II heterodimers: Aalpha(d)Abeta(b) heterodimers participate in early endosomal processing.
    Askew D; Harding CV
    Eur J Immunol; 2002 Oct; 32(10):2726-36. PubMed ID: 12355424
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antigen processing and presentation in human muscle: cathepsin S is critical for MHC class II expression and upregulated in inflammatory myopathies.
    Wiendl H; Lautwein A; Mitsdörffer M; Krause S; Erfurth S; Wienhold W; Morgalla M; Weber E; Overkleeft HS; Lochmüller H; Melms A; Tolosa E; Driessen C
    J Neuroimmunol; 2003 May; 138(1-2):132-43. PubMed ID: 12742663
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Splenic cathepsin L is maturated from the proform by interferon-gamma after immunization with exogenous antigens.
    Zhang T; Maekawa Y; Sakai T; Nakano Y; Ishii K; Hisaeda H; Kominami E; Katunuma N; Asao T; Himeno K
    Biochem Biophys Res Commun; 2001 May; 283(2):499-506. PubMed ID: 11327729
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Interferon-γ treatment in vitro elicits some of the changes in cathepsin S and antigen presentation characteristic of lacrimal glands and corneas from the NOD mouse model of Sjögren's Syndrome.
    Meng Z; Klinngam W; Edman MC; Hamm-Alvarez SF
    PLoS One; 2017; 12(9):e0184781. PubMed ID: 28902875
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inhibition of cathepsin S reduces allogeneic T cell priming but not graft-versus-host disease against minor histocompatibility antigens.
    Fujii H; Ivison SM; Shimizu H; Kajiwara R; Kariminia A; Yan M; Dutz JP; Schultz KR
    Biol Blood Marrow Transplant; 2012 Apr; 18(4):546-56. PubMed ID: 22178962
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.